These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25430875)

  • 1. The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
    Runia TF; Neuteboom RF; de Groot CJ; de Rijke YB; Hintzen RQ
    Eur J Neurol; 2015 Mar; 22(3):479-84. PubMed ID: 25430875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and vitamin D during pregnancy and lactation.
    Jalkanen A; Kauko T; Turpeinen U; Hämäläinen E; Airas L
    Acta Neurol Scand; 2015 Jan; 131(1):64-7. PubMed ID: 25216350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.
    Laursen JH; Søndergaard HB; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2016 Nov; 10():169-173. PubMed ID: 27919484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
    Smolders J; Menheere P; Kessels A; Damoiseaux J; Hupperts R
    Mult Scler; 2008 Nov; 14(9):1220-4. PubMed ID: 18653736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Blizzard L; Ponsonby AL; Pittas F; Tremlett H; Dwyer T; Gies P; van der Mei I
    Ann Neurol; 2010 Aug; 68(2):193-203. PubMed ID: 20695012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.
    Lin R; Taylor BV; Simpson S; Charlesworth J; Ponsonby AL; Pittas F; Dwyer T; van der Mei IA
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):399-404. PubMed ID: 23868949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
    Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
    Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D levels and perinatal depressive symptoms in women at risk: a secondary analysis of the mothers, omega-3, and mental health study.
    Williams JA; Romero VC; Clinton CM; Vazquez DM; Marcus SM; Chilimigras JL; Hamilton SE; Allbaugh LJ; Vahratian AM; Schrader RM; Mozurkewich EL
    BMC Pregnancy Childbirth; 2016 Aug; 16(1):203. PubMed ID: 27485050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
    Smolders J; Peelen E; Thewissen M; Menheere P; Damoiseaux J; Hupperts R
    Mult Scler; 2014 Apr; 20(4):433-7. PubMed ID: 23959712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C; Zeng Z; Wang B; Guo S
    J Nutr Health Aging; 2018; 22(1):38-43. PubMed ID: 29300420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
    Runia TF; Hop WC; de Rijke YB; Buljevac D; Hintzen RQ
    Neurology; 2012 Jul; 79(3):261-6. PubMed ID: 22700811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal variations of 25-OH vitamin D serum levels are associated with clinical disease activity in multiple sclerosis patients.
    Hartl C; Obermeier V; Gerdes LA; Brügel M; von Kries R; Kümpfel T
    J Neurol Sci; 2017 Apr; 375():160-164. PubMed ID: 28320120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects of Vitamin D in multiple sclerosis.
    Correale J; Ysrraelit MC; Gaitán MI
    Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D, pregnancy, breastfeeding, and postpartum multiple sclerosis relapses.
    Langer-Gould A; Huang S; Van Den Eeden SK; Gupta R; Leimpeter AD; Albers KB; Horst R; Hollis B; Steinman L; Nelson LM
    Arch Neurol; 2011 Mar; 68(3):310-3. PubMed ID: 21059988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis.
    Soilu-Hänninen M; Airas L; Mononen I; Heikkilä A; Viljanen M; Hänninen A
    Mult Scler; 2005 Jun; 11(3):266-71. PubMed ID: 15957505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Parathyroid Hormone and 25-Hydroxyvitamin D During and After Pregnancy.
    Kramer CK; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1729-36. PubMed ID: 26895390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Status in Women with Gestational Diabetes Mellitus during Pregnancy and Postpartum.
    Pleskačová A; Bartáková V; Pácal L; Kuricová K; Bělobrádková J; Tomandl J; Kaňková K
    Biomed Res Int; 2015; 2015():260624. PubMed ID: 26000285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.
    Ferre' L; Clarelli F; Sferruzza G; Rocca MA; Mascia E; Radaelli M; Sangalli F; Dalla Costa G; Moiola L; Aboulwafa M; Martinelli Boneschi F; Comi G; Filippi M; Martinelli V; Esposito F
    Neurol Sci; 2018 Aug; 39(8):1467-1470. PubMed ID: 29756179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.